Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)—Analysis of Data from Daily Practice

Remdesivir was the first antiviral approved for treating COVID-19. We investigated its patterns of use, effectiveness and safety in clinical practice in Greece. This is a retrospective observational study of hospitalized adults who received remdesivir for COVID-19 in September 2020–February 2021. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantazis, Nikos, Pechlivanidou, Evmorfia, Antoniadou, Anastasia, Akinosoglou, Karolina, Kalomenidis, Ioannis, Poulakou, Garyfallia, Milionis, Haralampos, Panagopoulos, Periklis, Marangos, Markos, Katsarolis, Ioannis, Kazakou, Pinelopi, Dimakopoulou, Vasiliki, Chaliasou, Anna-Louiza, Rapti, Vasiliki, Christaki, Eirini, Liontos, Angelos, Petrakis, Vasileios, Schinas, Georgios, Biros, Dimitrios, Rimpa, Maria-Christina, Touloumi, Giota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459397/
https://www.ncbi.nlm.nih.gov/pubmed/37630558
http://dx.doi.org/10.3390/microorganisms11081998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459397/
https://www.ncbi.nlm.nih.gov/pubmed/37630558
http://dx.doi.org/10.3390/microorganisms11081998

Ejemplares similares